Alphatec Holdings
ATEC
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$8.6m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Price at Q2 ’26 end
$8.65
-20.5% in the quarter
Share price change by quarter
-46.8%Q3 ’24
+65.1%Q4 ’24
+10.5%Q1 ’25
+9.5%Q2 ’25
+31.0%Q3 ’25
+44.7%Q4 ’25
-48.3%Q1 ’26
-20.5%Q2 ’26
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
1Q2 ’24
1Q3 ’24
1Q4 ’24
1Q1 ’25
2Q2 ’25
2Q3 ’25
2Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| First Eagle Investment Management | 0.0%$8.6m | Added +43% |
Directors buying and selling
How this works
| Bought or sold | ||||
|---|---|---|---|---|
| 10 Sep 2026 | Miles PatrickCEO | ▲ Bought | 115,000 | $1.0m |
| 5 Aug 2026 | Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC. | ▼ Sold | 8,168 | $79k |
About the company
- Sector
- Health care · Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 154m at 28 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$205m2013
$134m2015
$102m2017
2019
2021
2023
2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | – | −$143m |
| 2024 | – | −$162m |
| 2023 | – | −$187m |
| 2022 | – | −$151m |
| 2021 | – | −$143m |
| 2020 | – | −$79.0m |
| 2019 | – | −$57.0m |
| 2018 | – | −$29.0m |
| 2017 | $102m | −$2.3m |
| 2016 | $120m | −$29.9m |
| 2015 | $134m | −$179m |
| 2014 | $155m | −$12.9m |
| 2013 | $205m | −$82.2m |